Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 100

1.

Effects of plant species, stage of maturity, and level of formic acid addition on lipolysis, lipid content, and fatty acid composition during ensiling.

Koivunen E, Jaakkola S, Heikkilä T, Lampi AM, Halmemies-Beauchet-Filleau A, Lee MR, Winters AL, Shingfield KJ, Vanhatalo A.

J Anim Sci. 2015 Sep;93(9):4408-23. doi: 10.2527/jas.2014-8813.

2.

Targeting IL11 Receptor in Leukemia and Lymphoma: A Functional Ligand-Directed Study and Hematopathology Analysis of Patient-Derived Specimens.

Karjalainen K, Jaalouk DE, Bueso-Ramos C, Bover L, Sun Y, Kuniyasu A, Driessen WH, Cardó-Vila M, Rietz C, Zurita AJ, O'Brien S, Kantarjian HM, Cortes JE, Calin GA, Koivunen E, Arap W, Pasqualini R.

Clin Cancer Res. 2015 Jul 1;21(13):3041-51. doi: 10.1158/1078-0432.CCR-13-3059. Epub 2015 Mar 16.

3.

Design, development, and validation of a high-throughput drug-screening assay for targeting of human leukemia.

Karjalainen K, Pasqualini R, Cortes JE, Kornblau SM, Lichtiger B, O'Brien S, Kantarjian HM, Sidman RL, Arap W, Koivunen E.

Cancer. 2014 Feb 15;120(4):589-602. doi: 10.1002/cncr.28419. Epub 2013 Oct 25.

4.

In vivo targeting of activated leukocytes by a β2-integrin binding peptide.

Ranta TM, Suojanen J, Peñate-Medina O, Will O, Tower RJ, Glüer C, Kairemo K, Gahmberg CG, Koivunen E, Sorsa T, Saris PE, Reunanen J.

Mol Diagn Ther. 2014 Feb;18(1):39-44. doi: 10.1007/s40291-013-0052-5.

PMID:
23982749
5.

Autologous/reduced-intensity allogeneic stem cell transplantation vs autologous transplantation in multiple myeloma: long-term results of the EBMT-NMAM2000 study.

Gahrton G, Iacobelli S, Björkstrand B, Hegenbart U, Gruber A, Greinix H, Volin L, Narni F, Carella AM, Beksac M, Bosi A, Milone G, Corradini P, Schönland S, Friberg K, van Biezen A, Goldschmidt H, de Witte T, Morris C, Niederwieser D, Garderet L, Kröger N; EBMT Chronic Malignancies Working Party Plasma Cell Disorders Subcommittee.

Blood. 2013 Jun 20;121(25):5055-63. doi: 10.1182/blood-2012-11-469452. Epub 2013 Mar 12.

6.

Combinatorial targeting and discovery of ligand-receptors in organelles of mammalian cells.

Rangel R, Guzman-Rojas L, le Roux LG, Staquicini FI, Hosoya H, Barbu EM, Ozawa MG, Nie J, Jr KD, Langley RR, Sage EH, Koivunen E, Gelovani JG, Lobb RR, Sidman RL, Pasqualini R, Arap W.

Nat Commun. 2012 Apr 17;3:788. doi: 10.1038/ncomms1773.

7.

Cooperative effects of aminopeptidase N (CD13) expressed by nonmalignant and cancer cells within the tumor microenvironment.

Guzman-Rojas L, Rangel R, Salameh A, Edwards JK, Dondossola E, Kim YG, Saghatelian A, Giordano RJ, Kolonin MG, Staquicini FI, Koivunen E, Sidman RL, Arap W, Pasqualini R.

Proc Natl Acad Sci U S A. 2012 Jan 31;109(5):1637-42. doi: 10.1073/pnas.1120790109. Epub 2012 Jan 17.

8.

Vascular ligand-receptor mapping by direct combinatorial selection in cancer patients.

Staquicini FI, Cardó-Vila M, Kolonin MG, Trepel M, Edwards JK, Nunes DN, Sergeeva A, Efstathiou E, Sun J, Almeida NF, Tu SM, Botz GH, Wallace MJ, O'Connell DJ, Krajewski S, Gershenwald JE, Molldrem JJ, Flamm AL, Koivunen E, Pentz RD, Dias-Neto E, Setubal JC, Cahill DJ, Troncoso P, Do KA, Logothetis CJ, Sidman RL, Pasqualini R, Arap W.

Proc Natl Acad Sci U S A. 2011 Nov 15;108(46):18637-42. doi: 10.1073/pnas.1114503108. Epub 2011 Nov 2.

9.

Targeting neuropilin-1 in human leukemia and lymphoma.

Karjalainen K, Jaalouk DE, Bueso-Ramos CE, Zurita AJ, Kuniyasu A, Eckhardt BL, Marini FC, Lichtiger B, O'Brien S, Kantarjian HM, Cortes JE, Koivunen E, Arap W, Pasqualini R.

Blood. 2011 Jan 20;117(3):920-7. doi: 10.1182/blood-2010-05-282921. Epub 2010 Nov 9.

10.

A chimera of green fluorescent protein with gelatinase binding and tumor targeting peptide.

Reunanen J, Ranta TM, Peñate-Medina O, Suojanen J, Sorsa T, Salo T, Koivunen E, Saris PE.

Protein Expr Purif. 2010 Aug;72(2):234-7. doi: 10.1016/j.pep.2010.03.023. Epub 2010 Apr 3.

PMID:
20371289
11.

Identification of novel peptide inhibitors for human trypsins.

Wu P, Weisell J, Pakkala M, Peräkylä M, Zhu L, Koistinen R, Koivunen E, Stenman UH, Närvänen A, Koistinen H.

Biol Chem. 2010 Feb-Mar;391(2-3):283-93. doi: 10.1515/BC.2010.030.

PMID:
20128688
12.

Human Siglec-10 can bind to vascular adhesion protein-1 and serves as its substrate.

Kivi E, Elima K, Aalto K, Nymalm Y, Auvinen K, Koivunen E, Otto DM, Crocker PR, Salminen TA, Salmi M, Jalkanen S.

Blood. 2009 Dec 17;114(26):5385-92. doi: 10.1182/blood-2009-04-219253. Epub 2009 Oct 27.

13.

A novel and selective membrane type-1 matrix metalloproteinase (MT1-MMP) inhibitor reduces cancer cell motility and tumor growth.

Suojanen J, Salo T, Koivunen E, Sorsa T, Pirilä E.

Cancer Biol Ther. 2009 Dec;8(24):2362-70. Epub 2009 Dec 19.

PMID:
19855192
14.

Role of leukemia cell invadosome in extramedullary infiltration.

Stefanidakis M, Karjalainen K, Jaalouk DE, Gahmberg CG, O'Brien S, Pasqualini R, Arap W, Koivunen E.

Blood. 2009 Oct 1;114(14):3008-17. doi: 10.1182/blood-2008-04-148643. Epub 2009 Jul 27.

15.

An unrecognized extracellular function for an intracellular adapter protein released from the cytoplasm into the tumor microenvironment.

Mintz PJ, Cardó-Vila M, Ozawa MG, Hajitou A, Rangel R, Guzman-Rojas L, Christianson DR, Arap MA, Giordano RJ, Souza GR, Easley J, Salameh A, Oliviero S, Brentani RR, Koivunen E, Arap W, Pasqualini R.

Proc Natl Acad Sci U S A. 2009 Feb 17;106(7):2182-7. doi: 10.1073/pnas.0807543105. Epub 2009 Jan 23.

16.

Bortezomib plus melphalan and prednisone for initial treatment of multiple myeloma.

San Miguel JF, Schlag R, Khuageva NK, Dimopoulos MA, Shpilberg O, Kropff M, Spicka I, Petrucci MT, Palumbo A, Samoilova OS, Dmoszynska A, Abdulkadyrov KM, Schots R, Jiang B, Mateos MV, Anderson KC, Esseltine DL, Liu K, Cakana A, van de Velde H, Richardson PG; VISTA Trial Investigators.

N Engl J Med. 2008 Aug 28;359(9):906-17. doi: 10.1056/NEJMoa0801479.

17.

Combinatorial targeting of the macropinocytotic pathway in leukemia and lymphoma cells.

Nishimura S, Takahashi S, Kamikatahira H, Kuroki Y, Jaalouk DE, O'Brien S, Koivunen E, Arap W, Pasqualini R, Nakayama H, Kuniyasu A.

J Biol Chem. 2008 Apr 25;283(17):11752-62. doi: 10.1074/jbc.M708849200. Epub 2008 Feb 21.

18.

AlphaMbeta2 integrin modulator exerts antitumor activity in vivo.

Suojanen J, Salo T, Sorsa T, Koivunen E.

Anticancer Res. 2007 Nov-Dec;27(6B):3775-81.

19.

Blood stem cell mobilization and collection in patients with chronic lymphocytic leukaemia: a nationwide analysis.

Jantunen E, Itälä M, Siitonen T, Kuittinen T, Heiskanen J, Koivunen E, Juvonen E, Silvennoinen R, Nousiainen T, Koistinen P, Volin L, Remes K.

Bone Marrow Transplant. 2008 Feb;41(3):239-44. Epub 2007 Oct 29.

PMID:
17968327
20.

Long-term outcome of intensive chemotherapy for adults with de novo acute myeloid leukaemia (AML): the nationwide AML-92 study by the Finnish Leukaemia Group.

Koistinen P, Räty R, Itälä M, Jantunen E, Koivunen E, Nousiainen T, Pelliniemi TT, Remes K, Ruutu T, Savolainen ER, Siitonen T, Silvennoinen R, Volin L, Elonen E; Finnish Leukaemia Group.

Eur J Haematol. 2007 Jun;78(6):477-86. Epub 2007 Mar 28.

PMID:
17391337
Items per page

Supplemental Content

Loading ...
Write to the Help Desk